enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Calaspargase pegol - Wikipedia

    en.wikipedia.org/wiki/Calaspargase_pegol

    Calaspargase pegol, sold under the brand name Asparlas, is a medication for the treatment of acute lymphoblastic leukemia (ALL). It is approved in the United States as a component of a multi-agent chemotherapeutic regimen for ALL in pediatric and young adult patients aged one month to 21 years.

  3. Commonly prescribed drugs - Wikipedia

    en.wikipedia.org/wiki/Commonly_prescribed_drugs

    The use of commonly prescribed drugs can be reflected from the number of prescriptions of the drugs. Countries have their own dataset in recording the trend of commonly prescribed drugs. For example, the United States uses the Medical Expenditure Panel Survey (MEPS) [ 1 ] and England uses the English Prescribing Dataset [ 2 ] to record the ...

  4. Cancer and Leukemia Group B - Wikipedia

    en.wikipedia.org/wiki/Cancer_and_Leukemia_Group_B

    (There was also an Acute Leukemia Group A, which later became the Children's Cancer Study Group. [1]) During this time, the group expanded to a national level. Holland became the new chairman in 1962 after Frei resigned. The group changed its name to Cancer and Leukemia Group B in 1976 to reflect its role with solid tumors as well as leukemia.

  5. Tioguanine - Wikipedia

    en.wikipedia.org/wiki/Tioguanine

    Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) or tabloid is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and chronic myeloid leukemia (CML). [2] Long-term use is not recommended. [2] It is given by mouth. [2]

  6. Ponatinib - Wikipedia

    en.wikipedia.org/wiki/Ponatinib

    As of 2015, ponatinib is available in England for the treatment of chronic myeloid leukemia (chronic phase, accelerated phase or blast phase) and Philadelphia-positive acute lymphoblastic leukemia in patients with documented T315I mutation under the Cancer Drugs Fund, [20] and has not been appraised by the National Institute for Health and Care ...

  7. 5 Things You Should Know About DLBCL, the Most Common ...

    www.aol.com/5-things-know-dlbcl-most-130022299.html

    Non-Hodgkin’s lymphoma (NHL) is one of the most common forms of blood cancer.1 The American Cancer Society estimates that about 81,560 people in the U.S. will be diagnosed with NHL and about ...

  8. Why Doctors Are Calling This Common Medication a ... - AOL

    www.aol.com/why-doctors-calling-common...

    While it was once “just” a medication for people with type 2 diabetes, metformin is now thought of as a “wonder drug with multiple potentials,” says David Cutler, M.D., a family medicine ...

  9. Venetoclax - Wikipedia

    en.wikipedia.org/wiki/Venetoclax

    It is marketed by both Abbvie and Genentech USA, which is a member of the Roche Group. [14] AbbVie and Genentech are both commercializing the drug within the United States, but only AbbVie has rights to do so outside of the U.S. [20] According to Reuters 2016 Drugs to Watch, the 2020 forecast sales for venetoclax are US$1.48 billion.